For the year ending 2025-12-31, DYN has $1,186,958K in assets. $214,829K in debts. $893,369K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 893,369 | |||
| Marketable securities | 217,193 | |||
| Prepaid expenses and other current assets | 16,025 | |||
| Total current assets | 1,126,587 | |||
| Property and equipmentat cost | 32,750 | |||
| Less accumulated depreciation and amortization | 8,721 | |||
| Property and equipment, net | 24,029 | |||
| Right-of-use assets | 20,742 | |||
| Restricted cash and other assets | 15,600 | |||
| Total assets | 1,186,958 | |||
| Accounts payable | 8,082 | |||
| Accrued expenses and other current liabilities | 37,548 | |||
| Lease liabilities | 4,995 | |||
| Total current liabilities | 50,625 | |||
| Long-term debt, net | 148,921 | |||
| Lease liabilities, net of current portion | 15,283 | |||
| Total liabilities | 214,829 | |||
| Common stock, 0.0001 par value 200,000,000 shares authorized at december 31, 2025 and 2024 164,950,540 and 102,318,629 shares issued and outstanding at december 31, 2025 and 2024, respectively | 16 | |||
| Additional paid-in capital | 2,367,780 | |||
| Accumulated other comprehensive gain | 475 | |||
| Accumulated deficit | -1,396,142 | |||
| Total stockholders equity | 972,129 | |||
| Total liabilities and stockholders equity | 1,186,958 | |||
Dyne Therapeutics, Inc. (DYN)
Dyne Therapeutics, Inc. (DYN)